Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · December 27, 2022

Beta-Blocker Monotherapy or Combined Beta-Blocker and Amiodarone Therapy in Patients With ICDs or CRT-Ds

Heart Rhythm

 

Additional Info

Disclosure statements are available on the authors' profiles:

Heart Rhythm
Single beta-blocker or combined amiodarone therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy defibrillator patients - insights from the German DEVICE-registry
Heart Rhythm 2022 Dec 09;[EPub Ahead of Print], F Wiedmann, H Ince, C Stellbrink, T Kleemann, L Eckardt, J Brachmann, BD Gonska, S Kääb, CA Perings, W Jung, P Lugenbiel, M Hochadel, J Senges, N Frey, C Schmidt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading